eletriptan hydrobromide

FDA Drug Profile — Relpax, Eletriptan Hydrobromide, eletriptan hydrobromide

eletriptan hydrobromide is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including Relpax, Eletriptan Hydrobromide, eletriptan hydrobromide. Available dosage forms: tablet, tablet, film coated.

Drug details

Generic Name
eletriptan hydrobromide
Brand Names
Relpax, Eletriptan Hydrobromide, eletriptan hydrobromide
Application Number
NDA021016
Sponsor
Viatris Specialty LLC
NDC Codes
7
Dosage Forms
TABLET, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
ELETRIPTAN HYDROBROMIDE

Indications and Usage

1 INDICATIONS AND USAGE Eletriptan Hydrobromide Tablets is indicated for the acute treatment of migraine with or without aura in adults. Eletriptan Hydrobromide Tablets is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use: Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 ) Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with Eletriptan Hydrobromide Tablets, reconsider the diagnosis of migraine before Eletriptan Hydrobromide Tablets is administered to treat any subsequent attacks. Eletriptan Hydrobromide Tablets is not intended for the prevention of migraine attacks. Safety and effectiveness of Eletriptan Hydrobromide Tablets have not been established for cluster headache.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.